US BROKER MOVES: TMUS upgraded at Daiwa; HUN downgraded at JPM

UPGRADES ZIM Integrated Shipping (ZIM) upgraded from Sell to Neutral at Citi; PT USD 31.80 T-Mobile (TMUS) upgraded from Neutral to Outperform at Daiwa; PT USD 240 Symbotic (SYM) upgraded from Neutral to Overweight at KeyBanc; PT USD 70 QuantumScape (QS) upgraded from Sell to Hold at HSBC; PT USD 8.30 Nicolet Bankshares (NIC) upgraded from Neutral to Overweight at Piper Sandler Neptune Insurance (NP) upgraded from Neutral to Outperform at KBW; PT USD 25 LeonaBio Inc (LONA) upgraded from Neutral to Outperform at Mizuho Securities Garmin (GRMN) upgraded from Underweight to Equal-Weight at Morgan Stanley; PT USD 252 Dentsply (XRAY) upgraded from Neutral to Buy at BofA; PT USD 17 Cineverse Corp (CNVS) upgraded from Neutral to Buy at Benchmark; PT USD 12 Chewy (CHWY) upgraded from Neutral to Outperform at Raymond James; PT USD 28 DOWNGRADES SimilarWeb (SMWB) downgraded from Buy to Hold at Needham RF Industries (RFIL) downgraded from Buy to Neutral at B Riley; PT USD 10.25 Polestar (PSNY) ADRs downgraded from Neutral to Underweight at Cantor Mister Car Wash (MCW) downgraded from Buy to Neutral at Mizuho Securities; PT USD 7 Huntsman (HUN) downgraded from Overweight to Neutral at JPMorgan; PT USD 14 HF Sinclair (DINO) downgraded from Outperform to Sector Perform at Scotiabank; PT USD 53 Fiverr (FVRR) downgraded from Overweight to Neutral at JPMorgan; PT USD 15 Cheesecake Factory (CAKE) downgraded from Overweight to Equal-Weight at Stephens; PT USD 65 INITIATIONS Tempus AI (TEM) initiated at Outperform at Mizuho Securities; PT USD 100 Surrozen (SRZN) initiated at Overweight at Cantor; PT USD 40 Rhythm Pharma (RYTM) initiated at Outperform at RBC; PT USD 145 Perspective Therapeutics (CATX) initiated at Overweight at Piper Sandler Lear (LEA) initiated at Buy at Benchmark; PT USD 170 Kiniksa Pharmaceuticals (KNSA) initiated at Buy at Canaccord; PT USD 62 Grail (GRAL) initiated at Hold at TD Cowen; PT USD 114 Fossil (FOSL) initiated at Outperform at Northland; PT USD 7 Credo Technology (CRDO) initiated at Buy at Goldman; PT USD 165 BioHarvest Sciences Inc (BHST) initiated at Buy at Roth Capital Partners Axogen (AXGN) initiated at Overweight at Wells Fargo; PT USD 40